Nicolas O Amiano
Overview
Explore the profile of Nicolas O Amiano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
72
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amiano N, Pellegrini J, Morelli M, Martinena C, Rolandelli A, Castello F, et al.
Front Cell Infect Microbiol
. 2022 Apr;
12:841741.
PMID: 35360105
Alterations of myeloid cell populations have been reported in patients with tuberculosis (TB). In this work, we studied the relationship between myeloid-derived suppressor cells (MDSC) and monocytes subsets with the...
2.
Amiano N, Morelli M, Pellegrini J, Tateosian N, Rolandelli A, Seery V, et al.
Sci Rep
. 2020 May;
10(1):7472.
PMID: 32366931
Tuberculin skin test (TST) and IFN-γ release assays are currently used to detect Mycobacterium tuberculosis (Mtb) infection but none of them differentiate active from latent infection (LTBI). Since improved tests...
3.
Rolandelli A, Pellegrini J, Amiano N, Santilli M, Morelli M, Castello F, et al.
Genes (Basel)
. 2018 Jan;
9(1).
PMID: 29361774
Interferon gamma (IFNG) plays a key role during () infection, and several polymorphisms located in its gene are associated with risk of tuberculosis in diverse populations. Nevertheless, the genetic resistance/susceptibility...
4.
Pena D, Rovetta A, Hernandez Del Pino R, Amiano N, Pasquinelli V, Pellegrini J, et al.
EBioMedicine
. 2015 Oct;
2(8):884-90.
PMID: 26425695
IFN-γ release assays (IGRAs) are better indicators of Mycobacterium tuberculosis infection than the tuberculin skin test (TST) in Bacillus Calmette-Guérin (BCG)-vaccinated populations. However, IGRAs do not discriminate active and latent...
5.
Amiano N, Costa M, Reiteri R, Payes C, Guerrieri D, Tateosian N, et al.
J Cell Physiol
. 2012 Jul;
228(2):469-75.
PMID: 22767220
Secretory leukocyte protease inhibitor (SLPI) is a serine protease inhibitor that was related to cancer development and metastasis dissemination on several types of tumors. However, it is not known the...
6.
Guerrieri D, Tateosian N, Maffia P, Reiteri R, Amiano N, Costa M, et al.
Immunology
. 2011 May;
133(4):434-41.
PMID: 21574992
Serine leucocyte proteinase inhibitor (SLPI) is the main serine proteinase inhibitor produced by epithelial cells and has been shown to be a pleiotropic molecule with anti-inflammatory and microbicidal activities. However,...
7.
Gomez S, Arguelles C, Guerrieri D, Tateosian N, Amiano N, Slimovich R, et al.
Am J Respir Crit Care Med
. 2008 Nov;
179(3):247-53.
PMID: 19011154
Rationale: Human secretory leukocyte protease inhibitor (SLPI) displays bactericidal activity against pathogens such as Escherichia coli and Streptococcus. Furthermore, it has been reported that murine SLPI shows potent antimycobacterial activity....